Call Today for a FREE Confidential Case Review
Toll-Free 24/7 (866) 920-0753

FDA Adds ‘Black Box’ Label for Invokana Amputation Risk

May 16, 2017 — The diabetes drugs Invokana and Invokamet will now carry a “Black Box” warning that they double a patient’s risk of leg and foot amputations. The FDA required its strongest warning label after reviewing final results from the CANVAS...

Bullous Pemphigoid Lawsuit

Januvia and other diabetes drugs in the DPP-4 inhibitor class may cause bullous pemphigoid, a rare but extremely painful skin reaction with blisters and lesions. What You Can Do & How We Can Help The Schmidt Firm, PLLC is currently accepting diabetes drug induced...

Xarelto Trials Start on April 24 Unless Lawyers Reach Settlement

April 5, 2017 — The first “bellwether” trial out of 17,000 Xarelto lawsuits involving uncontrollable bleeding is set for April 24, followed by another trial on May 30, unless lawyers agree on a settlement this month. There are currently 1,343 lawsuits...

J&J Facing Over 18,500 Risperdal Gynecomastia Lawsuits

April 4, 2017 — Over 18,500 lawsuits have been filed by young men who developed female breasts after taking Risperdal, an anti-psychotic drug made by Johnson & Johnson. Johnson & Johnson reported 103,000 lawsuits to the U.S. Securities and Exchange Commission...

Viberzi Class Action Lawsuit

Viberzi is a new type of anti-diarrhea drug that has been linked to 120 reports of pancreas inflammation (pancreatitis) or death. The FDA recently warned that people without a gallbladder have the highest risk of these life-threatening side effects. What You Can Do...

Viberzi Lawsuit

Viberzi is an anti-diarrhea medication that has been linked to 120 reports of severe pancreas inflammation (pancreatitis) and death. People without gallbladders are more likely to suffer life-threatening side effects of Viberzi. What You Can Do & How We Can Help...